Navigation Links
UCB Announces Positive Phase III Trial Results for Keppra XR(TM) (levetiracetam) Extended-Release Tablets
Date:12/3/2007

Keppra XR(TM) significantly reduced partial onset seizure frequency when administered as adjunctive therapy for adults with refractory epilepsy.

ATLANTA, Dec. 3 /PRNewswire/ -- UCB today announced results of a Phase III trial demonstrating that its antiepileptic drug (AED) in development Keppra XR(TM) (levetiracetam) extended-release tablets significantly reduced partial onset seizure frequency when administered as adjunctive therapy for adults with refractory epilepsy. These data were presented today at a scientific exhibit at the 61st annual meeting of the American Epilepsy Society, Philadelphia.

"These data show that the once-daily, extended-release formulation of Keppra(R) reduced the frequency of partial onset seizures in patients with uncontrolled epilepsy and was generally well tolerated," said Iris Loew-Friedrich, MD, PhD, Global Head of Development, UCB.

The Phase III, multicenter, randomized, double-blind, placebo-controlled study evaluated efficacy, safety, and tolerability of extended-release levetiracetam tablets (2x500 mg) once-daily as adjunctive therapy in 158 refractory epilepsy patients, 12 to 70 years of age, with partial onset seizures.

The study met its primary endpoint for seizure reduction over placebo during the treatment period (p=0.038). The median percent reduction of partial onset seizures in the extended-release levetiracetam group was 46.1% compared to 33.4% with placebo during the 12 week treatment period. Additionally, 24.0% of patients randomized to the extended-release levetiracetam group had seizure frequency per week reduced by 75-100%, compared with 11.4% of patients in the placebo group. In the extended-release levetiracetam group 10.1% of patients had 100% reduction in partial onset seizures and 8.9% were free from any type of seizure over the treatment period, compared to 2.5% and 1.3% in the placebo group, respectively.

The study also found that extended-release levetiracetam tablets
'/>"/>

SOURCE UCB, Inc.
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
2. EDAP Announces Launch of Clinical Study Combining HIFU and Chemotherapy for Localized Aggressive High Risk Prostate Cancer
3. Cephalon Announces Positive Results from a Pivotal Study of FENTORA in Opioid-tolerant Patients with Non-cancer Breakthrough Pain
4. ADVENTRX Announces Fast Track Designation Granted By the FDA For CoFactor For the Treatment of Metastatic Colorectal Cancer
5. DOV Pharmaceutical, Inc. Announces Successful Phase Ib Results for DOV 21,947
6. Phosphagenics Announces Positive Phase 1b Transdermal Insulin Clinical Trial Results
7. Xenomics Announces Implementation of its First Diagnostic Test for Acute Myeloid Leukemia Into Clinical Practice
8. Emisphere Technologies, Inc. Announces 2007 Second Quarter Financial Results
9. Amicus Therapeutics Announces Second Quarter 2007 Financial Results
10. Genta Incorporated Announces Second Quarter 2007 Financial Results and Corporate Highlights
11. MicroDose Announces Positive Results From the QDose Inhaled Insulin Glucose Clamp Study
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/18/2014)... 2014 Just days before the government of ... contain the spread of Ebola, World Vision will begin a ... thanks to private donations. McKesson, the largest healthcare ... through its affiliate McKesson Medical-Surgical donated four million pairs of ... Sierra Leone,s needs for the next ...
(Date:9/18/2014)... MOUNTAIN VIEW, Calif. and CHESTERBROOK, Pa. ... (Nasdaq: VVUS ) and Auxilium Pharmaceuticals, ... the U.S. Food and Drug Administration (FDA) has approved a ... STENDRA is now the only FDA-approved erectile dysfunction (ED) medication ... before sexual activity. STENDRA is a prescription medication ...
(Date:9/17/2014)... /PRNewswire-iReach/ -- DeepResearchReports.com adds "2014 Market Research Report ... Market Research Report on Global and China Isothiocyanate ... Photo - http://photos.prnewswire.com/prnh/20140917/146748 ... Methacrylate (MMA) Industry" is a professional and in-depth ... and Global Methyl Methacrylate (MMA) market. The report ...
Breaking Medicine Technology:World Vision, McKesson, Other Donors Prepare for Massive Shipment of Medical Supplies to Support Sierra Leone Health Workers 2World Vision, McKesson, Other Donors Prepare for Massive Shipment of Medical Supplies to Support Sierra Leone Health Workers 3World Vision, McKesson, Other Donors Prepare for Massive Shipment of Medical Supplies to Support Sierra Leone Health Workers 4VIVUS And Auxilium Announce FDA Approval Of STENDRA sNDA; STENDRA Now First And Only Oral Erectile Dysfunction Treatment Approved To Be Taken Approximately 15 Minutes Before Sexual Activity 2VIVUS And Auxilium Announce FDA Approval Of STENDRA sNDA; STENDRA Now First And Only Oral Erectile Dysfunction Treatment Approved To Be Taken Approximately 15 Minutes Before Sexual Activity 3VIVUS And Auxilium Announce FDA Approval Of STENDRA sNDA; STENDRA Now First And Only Oral Erectile Dysfunction Treatment Approved To Be Taken Approximately 15 Minutes Before Sexual Activity 4VIVUS And Auxilium Announce FDA Approval Of STENDRA sNDA; STENDRA Now First And Only Oral Erectile Dysfunction Treatment Approved To Be Taken Approximately 15 Minutes Before Sexual Activity 5VIVUS And Auxilium Announce FDA Approval Of STENDRA sNDA; STENDRA Now First And Only Oral Erectile Dysfunction Treatment Approved To Be Taken Approximately 15 Minutes Before Sexual Activity 6VIVUS And Auxilium Announce FDA Approval Of STENDRA sNDA; STENDRA Now First And Only Oral Erectile Dysfunction Treatment Approved To Be Taken Approximately 15 Minutes Before Sexual Activity 7VIVUS And Auxilium Announce FDA Approval Of STENDRA sNDA; STENDRA Now First And Only Oral Erectile Dysfunction Treatment Approved To Be Taken Approximately 15 Minutes Before Sexual Activity 8VIVUS And Auxilium Announce FDA Approval Of STENDRA sNDA; STENDRA Now First And Only Oral Erectile Dysfunction Treatment Approved To Be Taken Approximately 15 Minutes Before Sexual Activity 9Methyl Methacrylate Market & Chinese Isothiocyanate Industry Trend Development 2Methyl Methacrylate Market & Chinese Isothiocyanate Industry Trend Development 3Methyl Methacrylate Market & Chinese Isothiocyanate Industry Trend Development 4Methyl Methacrylate Market & Chinese Isothiocyanate Industry Trend Development 5
(Date:9/18/2014)... (PRWEB) September 18, 2014 Technology Association ... winners of its 2nd TAG Social Savvy Awards this ... Achievement’s Chick-fil-A Foundation Discovery Center in Downtown Atlanta. The ... , Turner Sports was honored with the 2014 ... year’s event also recognized innovators in 6 other award ...
(Date:9/18/2014)... A sold-out crowd of more than ... supported United Way of Westchester and Putnam ... event Monday, Sept. 15. Proceeds from the event will ... and Putnam, such as providing healthy foods to low-income ... risky behaviors like drug and alcohol usage. , Two ...
(Date:9/18/2014)... -- Teens and young adults who,ve been mentored may ... them with greater responsibility and independence early on in ... found that having a mentor provides a clear benefit ... Steve McDonald, an associate professor of sociology at North ... In conducting the study, published online recently ...
(Date:9/18/2014)... A common Asian spice and cancer-hampering molecules show ... cancer of the lung,s lining often linked to ... the Georg-Speyer-Haus in Frankfurt, Germany, demonstrate that application ... and cancer-inhibiting peptides increase levels of a protein ... cancer. Their findings appeared in the Aug. 14 ...
(Date:9/18/2014)... Research led by Paulo Rodriguez, PhD, an assistant research ... New Orleans, Stanley S. Scott Cancer Center, has identified ... plays in the body,s ability to fight cancer. Results ... activity and accumulation of cells that suppress the body,s ... research team showed that when they removed Chop, the ...
Breaking Medicine News(10 mins):Health News:Winners Honored at 2014 TAG Social Savvy Awards 2Health News:Winners Honored at 2014 TAG Social Savvy Awards 3Health News:United Way Celebrates “Best Chefs and Fine Wines” at Sold-Out Culinary Event 2Health News:United Way Celebrates “Best Chefs and Fine Wines” at Sold-Out Culinary Event 3Health News: Mentors May Steer Young People Toward More Rewarding Careers 2Health News:Curcumin, special peptides boost cancer-blocking PIAS3 to neutralize STAT3 in mesothelioma 2Health News:Curcumin, special peptides boost cancer-blocking PIAS3 to neutralize STAT3 in mesothelioma 3Health News:LSU Health research discovers means to free immune system to destroy cancer 2
... July 30 On Wednesday, July 30th,Representative Jose ... Act, a bill which, if passed, will remove ... spend federal funding that,they receive for prevention of ... method of HIV prevention which helps intravenous,drug users ...
... Company,s Fourth FDA 510(k) Clearance Since December 2007, ... Corp.,(Nasdaq: ESMC ) today announced that the ... the 510(k) submission for the LIASYS(TM),bench top clinical ... Diagnostic ("JAS") unit is the distributor,for the LIASYS ...
... CYT, MONTREAL, July 30 /PRNewswire-FirstCall/ - CryoCath ... products to treat cardiac,arrhythmias, today announced that Jan ... corporate update at the BMO Focus on Healthcare,Conference. ... at 8:30 a.m. (ET) in Room 2 at ...
... of Dr. Julius,Richmond, one of the founding fathers ... Americans who care about childhood education, health and ... (NHSA), the organization,representing children, family, educators and others ... education program., A statement issued today by ...
... travel to China for the 2008 Olympic Games, travelers ... bites, according to report by an Emory University travelers, ... Control and Prevention (CDC) and around the globe. ... rabies. The report finds that respiratory illnesses and dog ...
... American Association of Pharmaceutical Scientists (AAPS) will co-sponsor Immunogenicity ... , ... Horsham, PA ... (DIA) and the American Association of Pharmaceutical Scientists (AAPS) ...
Cached Medicine News:Health News:AIDS Action Applauds Introduction of a New Bill Allowing Federal Funds to Support Syringe Exchange Programs 2Health News:AIDS Action Applauds Introduction of a New Bill Allowing Federal Funds to Support Syringe Exchange Programs 3Health News:AIDS Action Applauds Introduction of a New Bill Allowing Federal Funds to Support Syringe Exchange Programs 4Health News:AIDS Action Applauds Introduction of a New Bill Allowing Federal Funds to Support Syringe Exchange Programs 5Health News:AIDS Action Applauds Introduction of a New Bill Allowing Federal Funds to Support Syringe Exchange Programs 6Health News:AIDS Action Applauds Introduction of a New Bill Allowing Federal Funds to Support Syringe Exchange Programs 7Health News:AIDS Action Applauds Introduction of a New Bill Allowing Federal Funds to Support Syringe Exchange Programs 8Health News:AIDS Action Applauds Introduction of a New Bill Allowing Federal Funds to Support Syringe Exchange Programs 9Health News:Escalon(R) Receives FDA 510(k) Clearance to Market the LIASYS(TM) Clinical Chemistry and Immunoturbidimetric Analyzer 2Health News:Escalon(R) Receives FDA 510(k) Clearance to Market the LIASYS(TM) Clinical Chemistry and Immunoturbidimetric Analyzer 3Health News:NHSA: Head Start Community Mourns Passing of Pioneer Dr. Julius Richmond 2Health News:Respiratory illnesses and dog bites a concern for travelers to China for 2008 Olympics 2Health News:DIA/AAPS Co-Sponsored Conference to Examine the Immunogenicity of Therapeutic Proteins 2
A versatile plate washer and/or dispenser that aspirates from the top down without immersing the aspirating tubes in the well, ensuring overflow protection. 5 programmable protocols....
... High performance plus simple ... gentle and efficient washing ... is performed with minimum ... cells while membrane bound ...
Stat Fax 2600 is fully automatic microplate washer....
The Microtech Microplate Washer (220 V) is a flexible and ultra compact microplate washer. The system offers a wide choice of washing functions and sequences designed to handle most any microplate ap...
Medicine Products: